Prognosis in Pregnant With COVID-19

Prognostic Factors in Pregnant Women With COVID-19

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04409249

Enrollment

155

Registered

2020-06-01

Start date

2020-03-15

Completion date

2020-05-28

Last updated

2020-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Pregnancy, Prognostic Factors

Brief summary

COVID-19 is a disease whose development, prognosis mechanism and immune status are still unknown. The aim of the study is to determine the relationship between clinical and laboratory data and the severity of the disease by evaluating the hematological and radiological features of the patients. The secondary aim is to determine the predictive values of clinical and laboratory data for the severity of COVID-19.

Interventions

DIAGNOSTIC_TESTimaging, blood tests

PCR and CT results, hemogram, urea, creatinine, AST, ALT, LDH, D-Dimer, ferritin, lipase, amylase, CRP, procalcitonin, albumin, total protein, coagulation tests-PT, APTT, Fibrinogen-, Troponin T, CK , electrolytes, blood gas, bilirubins

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Inclusion criteria

* Being pregnant with a diagnosis of COVID-19 between the ages of 18-45

Exclusion criteria

* Suspected COVID-19 diagnosis

Design outcomes

Primary

Measure	Time frame
the factors affecting prognosis in pregnant women diagnosed with COVID-19	3 Months

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026